1997年

  1. Takada H, Kishimoto C, Hiraoka Y, Kurokawa M, Shiraki K, Sasayama S: Captopril suppresses interstitial fibrin deposition in coxsackievirus B3 myocarditis. Am J Physiol 272: H211-H219.
  2. Ogawa J, Fujiwara H, Kawamura A, Katsuragawa M, Htay T, Fujiwara T, Hasegawa K, Yamasaki K, Tanaka M, Sasayama S: Acute cellular damage in madial smooth muscle cells following experimental coronary angioplasty in dog. Damage of cytoskeleton and apoptosis. Heart Vessels 12: 157-166, 1997.
  3. Ohtani S, Fujiwara H, Hasegawa K, Doyama K, Inada T, Tanaka M, Fujiwara T, Sasayama S: Up-regulated expression of angiotensinⅡtype 1 receptor gene in human pathologic hearts. J Cardiac Fail 3: 303-310, 1997.
  4. Matsumori A: Implications of cytokine inhibition for the drug therapy of heart failure. Bio Drugs 7: 107-118.
  5. Matsumori A: Molecular and immune mechanisms in the pathogenesis of cardiomyopathy. Jpn Circ J 61: 275-291.
  6. Matsumori A, Furukawa Y, Hashimoto T, Yoshida A, Ono K, Shioi T, Okada M, Iwasaki A, Nishio R, Matsushima K, Sasayama S: Plasma levels of the monocyte chemotactic and activating factor/monocyte chemotactic protein-1 are elevated in patients with acute myocardial infarction. J Mol Cell Cardiol 29: 419-423.
  7. Matsumori A, Ono K, Nishio R, Igata H, Shioi T, Matsui S, Furukawa Y, Iwasaki A, Nose Y, Sasayama S: Modulation of cytokine production and protection against lethal endotoxemia by the cardiac glycoside ouabain. Circulation 96: 1501-1506.
  8. Matsumori A, Ono K, Nishio R, Nose Y, Sasayama S: Amiodarone inhibits production of tumor necrosis factor-α by human mononuclear cells. A possible mechanism for its effect in heart failure. Circulation 96: 1386-1389.
  9. Wang W-Z, Matsumori A, Yamada T, Shioi T, Okada I, Matsui S, Sato Y, Suzuki H, Shiota K, Sasayama S: Beneficial effects of amlodipine in a murine model of congestive heart failure induced by viral myocarditis: A possible mechanism through inhibition of nitric oxide production. Circulation 95: 245-251.
  10. Hirozane T, Matsumori A, Furukawa Y, Matsui S, Matoba Y, Sasayama S: Prolongation of murine cardiac allograft survival with vesnarinone. J Mol Cell Cardiol 29: 67-76.
  11. Ono K, Matsumori A, Shioi T, Furukawa Y, Sasayama S: Enhanced expression of hepatocyte growth factor/c-met by myocardial ischemia and reperfusion in a rat model. Circulation 95: 2552-2558.
  12. Yamada T, Matsumori A, Tamaki N, Nohara R, Konishi J, Sasayama S: Indium-111 antimyosin antibody imaging and thallium-201 imaging: A comparative myocardial scintigraphic study using SPECT in patients with myocarditis and dilated cardiomyopathy. Jpn Circ J 61: 827-835.
  13. Shioi T, Matsumori A, Kihara Y, Inoko M, Ono K, Iwanaga Y, Yamada T, Iwasaki A, Matsushima K, Sasayama S: Increased expression of interleukin-1β and monocyte chemotactic and activating factor (MCAF)/ monocyte chemoattractant protein-1 (MCP-1) in the hypertrophied and failing heart with pressure overload. Circ Res 81: 664-671.
  14. Sato Y, Kataoka K, Matsumori A, Sasayama S, Yamada T, Ito H, Takasu Y: Measuring serum aminoterminal type III procollagen peptide, 7S domain of type IV collagen, and cardiac troponin T in patients with idiopathic dilated cardiomyopathy and secondary cardiomyopathy. HEART 78: 505-508.
  15. Shioi T, Matsumori A, Ono K, Nishio R, Kakio T, Sasayama S: Protective role of Interleukin-12 in viral myocarditis. J Mol Cell Cardiol 29: 2327-2334.
  16. Morita Y, Murakami T, Iwase T, Nagai K, Nawada R, Kouchi I, Akao M, Sasayama S: KATP channels contribute to the cardioprotection of preconditioning independent of anaesthetics in rabbit hearts. J Mol Cell Cardiol 29: 1267-1276.
  17. Nawada R, Murakami T, Iwase T, Nagai K, Morita Y, Kouchi I, Akao M, Sasayama S: Inhibition of sarcolemmal Na+, K+ -ATPase activity reduces the infarct size-limiting effect of preconditioning in rabbit hearts. Circulation 96: 599-604.
  18. Murakami T, Nawada R, Iwase T, Morita Y, Kouchi I, Akao M, Sasayama S: Sarcolemmal 5'-nucleotidase activity does not increase in preconditioned rabbit hearts. Cardiovasc Pathobiol 1: 172-179.
  19. Akao M, Otani H, Horie M, Takano M, Kuniyasu A, Nakayama H, Kouchi I, Sasayama S, Murakami T: Myocardial ischemia induces differential regulation of KATP channel gene expression in rat hearts. J Clin Invest 100: 3053-3059.
  20. Kasuno K, Ono T, Kamata T, Kawamura T, Suyama K, Oyama A, Matsushima H, Kuwahara T, Muso E, Sasayama S: IgA nephropathy associated with polycythemia vera: accelerated course. Nephrol Dial Transplant 12: 212-215.
  21. Miyawaki S, Muso E, Takeuchi E, Matsushima H, Shibata Y, Sasayama S, Yoshida H: Selective breeding for high serum IgA levels from nominbred ddY mice: Isolation of a strain with an early onset of glomerular IgA deposition. Nephron 76: 201-207.
  22. Ozaki K, Takada N, Tsujimoto K, Tsuji N, Kawamura T, Muso E, Ohta M, Itho N: Localization of insulin receptor-related receptor in the rat kidney. Kidney Int 52: 694-698.
  23. Haku E, Muso E, Nogaki F, Sakurai M, Kawamura T, Kamata T, Suyama K, Oyama A, Ono T, Sasayama S, Nishimoto E, Yoshimoto M, Uno K, Kishida T: Whole-blood interferon-producing capacity in IgA nephropathy patients. Nephrology 3 (Suppl.): A14.
  24. Otsuka N, Ohi M, Chin K, Kita H, Noguchi T, Hata T, Nohara R, Hosokawa R, Fujita M, Kuno K: Assessment of cardiac sympathetic function with Iodine-123-MIBG imaging in patients with obstructive sleep apnea syndrome. J Nucl Med 38:567-572.
  25. Hosokawa R, Nohara R, Fujibayashi Y, Okuda K, Ogino M, Hata T, Fujita M, Tamaki N, Konishi J, Sasayama S: Myocardial kinetics of iodine-123-BMIPP in canine myocardium after regional ischemia and reperfusion : Implications for clinical SPECT. J Nucl Med 38: 1857-1863.
  26. Kudoh T, Tamaki N, Magata Y, Konishi J, Nohara R, Iwasaki A, Ono S, Ohtake Y, Sugihara H, Kuze K, Tsujimura Y, Miyazaki T: Metabolism substrate with negative myocardial uptake of 123I-BMIPP. J Nucl Med 38:548-553.
  27. Watanuki M, Horie M, Tsuchiya K, Obayashi M, Sasayama S: Endothelin-1 inhibition of cardiac ATP -sensitive K channels via pertussis-toxin sensitive G proteins. Cardiovasc Res 33: 123-130.
  28. Obayashi K, Horie M, Xie L-H, Tsuchiya K, Kubota A, Ishida H, Sasayama S: Angiotensin-II inhibits protein kinase A-dependent Cl- conductance via PTX-sensitive G proteins in heart. Circulation 95: 197-204.
  29. Horie M, Ishida-Takahashi A, Ai T, Tsuura Y, Ishida H, Seino Y, Sasayama S: Review: Insulin secretion and its modulation by antiarrhythmic and sulfonylurea drugs. Cardiovasc Res 34: 69-72.
  30. Yuzuki Y, Horie M, Makita T, Watanuki M, Takahashi A, Nakajima H, Sasayama S: Exercise-induced second degree atrioventricular block. Jpn. Circ J 6: 268-271.31) Horie M, Tsuchiya K, Washizuka T, Obayashi K, Ai T, Nishimoto T, Takahashi A, Sasayama S: Functional communication between cardiac Na/K ATPase and ATP-sensitive K channels through [ATP] under the membrane. In: Under the membrane-signal trasduction and integration ed. Imoto K & Mori T, NIPS Press, Okazaki, pp 91-94.
  31. Horie M, Tsuchiya K, Washizuka T, Obayashi K, Ai T, Nishimoto T, Takahashi A, Sasayama S: Functional communication between cardiac Na/K ATPase and ATP-sensitive K channels through [ATP] under the membrane. In: Under the membrane-signal trasduction and integration ed. Imoto K & Mori T, NIPS Press, Okazaki, pp 91-94.
  32. Washizuka T, Horie M, Watanuki M, Sasayama S: Endothelin-1 inhibits the slow component of cardiac dekayed rectifier K+ currents via a pertussis toxin-sensitive mechanism. Circ Res 81: 211-218.
  33. Tsuchiya K, Horie M, Watanuki M, Albrecht CA, Obayashi K, Fujiwara H, Sasayama S: Functional compartmentalization of ATP is involved in the Angiotensin II-mediated closure of cardiac ATP-sensitive K+ channels. Circulation 96: 3129-3135.
  34. Washizuka T, Horie M, Obayashi K, Sasayama S: Does tyrosine kinase modulate delayed-rectifier K channels in guinea pig ventricular cells? Heart and Vessel Suppl 12: 173-174.
  35. Satoh H, Horie M: Actions of taurine on the L-type Ca2+ channel current in the guinea pig ventricular cardiomyocytes. J Cardiovasc Pharm 30: 711-716.
  36. Hisamatsu Y, Ohkusa T, Kihara Y, Inoko M, Ueyama T, Yano M, Sasayama S, Matsuzaki M: Early changes in the functions of cardiac sarcoplasmic reticulum in volume-overloaded cardiac hypertrophy in rats. J Mol Cell Cardiol 29: 1097-1109.
  37. Takagi S, Kihara Y, Wang Z, Mitsuiye T, Sasayama S: Effect of tilisolol, a non-selective β-adrenergic blocker, on the membrane currents of isolated guinea-pg ventricular myocytes. J Cardiovasc Pharm 29(5): 593-598.
  38. Kihara Y, Sasayama S: Transition from compensatory hypertrophy to dilated failing left ventricle in Dahl-Iwai salt-sensitive rats. Am J Hypertens 10: 78S- 82S.
  39. Kihara Y: The anti-arrhythmic effects and the negative inotropic effects of class Ic agents do not share the common underlying mechanism: the interaction with L-type calcium channel is important for the contractile suppression in diseased hearts. Ion Channel Modulatiors ID Research Alert 2: 285-288.
  40. Hasegawa K, Meyers M.B, Kitsis R.N: Transcriptional coactivator p300 stimulates cell typespecific gene expression in cardiac myocytes. J Biol Chem 272: 20049-20054.
  41. Hasegawa K, Lee S.J, Kitsis R.N: cic-Acting sequences that mediate induction of β-myosin heavy chain gene expression during left ventricular hypertrophy due to aortic constriction. Circulation 96: 3943-3953.
  42. Inoue K, Iwase T, Sato M, Yoshida Y, Tanaka T, Kubota Y, Tamaki S, Hasegawa K, Yamazato A : Clinical application of transluminal endovascular graft placement for aortic aneurysms. Ann-Thorac-Surg 53: 522-528.
  43. Yamasaki K, Fujiwara H, Tanaka M, Yokota R, Miyamae M, Ogawa J, Fujiwara T, Sasayama S: Preconditioning with 15-minute ischemia myocardial infarct size after subsequent 30-minute ischemia in rabbits. Jpn Circ J 61: 344-352.
  44. Hasegawa K, Kitsis R.N: Gene transfer into adult cardiac myocytes in vivo by direct injection of DNA. In Molecular Biology of Cardiovascular Disease., ed.by Marks AR and Taubman MB, Marcel Dekker, New York. 4: 67-80.
  45. Hayashida W, Donckier J, Van Mechelen H, Charlier AA, Pouleur H: Diastolic properties in canine hypertensive left ventricular hypertrophy: Effects of angiotensin converting enzyme inhibition and angiotensin II type-1 receptor blockade. Cardiovasc Res 33: 54-62.
  46. Horiuchi M, Yamada T, Hayashida W, Dzau VJ: Interferon regulatory factor-1 up-regulates angiotensin II type 2 receptor and induces apoptosis. J Biol Chem 272: 11952-11958.
  47. Horiuchi M, Hayashida W, Kambe T, Yamada T, Dzau VJ: Angiotensin type 2 receptor dephosphorylates Bcl-2 by activating mitogen-activated protein kinase phosphatase-1 and induces apoptosis. J Biol Chem 272: 19022-19026.
  48. Shioji K, Fujita M, Yamada T, Matsuda T, Nohara R, Sasayama S: Heparin and exercise treatment in a patient with arteriosclerosis obliterans. Jpn Circ J 61: 715-718.
  49. Fujita M, Nakae I, Fudo T, Tanaka T, Iwase T, Tamaki S, Nohara R, Sasayama S: Fate of collateral vessels after successful coronary angioplasty in patients with effort angina. J Am Coll Cardiol 29: 544-548.

ページの先頭へ